Renata Medical Closes $25 Million Series D Financing

Represented Renata Medical in connection with its $25 million Series D financing led by ARCHIMED, a global healthcare investment firm, to accelerate the commercialization and development of pediatric cardiovascular technologies.

Renata Medical develops cardiovascular technologies for children with congenital heart disease. The financing will support expanded U.S. commercialization of its Minima™ Stent System, entry into international markets, and continued development of its pipeline of pediatric cardiovascular technologies.